Related Experiment Video

Updated: Apr 28, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.7K

Heme products post-radiofrequency ablation obscure tumor recurrence on MR but not on PET-CT

Syed Ramisa Ehsan1, Casey E Gooden2, David M Schuster1

  • 1Division of Nuclear Medicine and Molecular Imaging, Emory University Hospital, Department of Radiology and Imaging Sciences, 1364 Clifton Road NE, Atlanta, GA 30322 USA.

Nuclear Medicine and Molecular Imaging
|June 6, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

5.5K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

8.9K

Related Concept Videos